A--Jackson Heart Study - Coordinating Center Renewal
ID: 75N92024R0259Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NHLBIBETHESDA, MD, 20892, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/opp/17276aec225448fa9aa26484053e020a/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the renewal of the Jackson Heart Study Coordinating Center. This opportunity aims to continue the essential research and development activities related to cardiovascular health, focusing on the coordination and management of the Jackson Heart Study, which is critical for understanding heart disease in African American populations. The selected contractor will be responsible for providing health research and development services, ensuring the study's objectives are met effectively. Interested parties can reach out to Matthew Jovinelli at matthew.jovinelli@nih.gov or (301) 827-8315 for further details regarding this presolicitation notice.

    Point(s) of Contact
    Jovinelli, Matthew
    (301) 827-8315
    matthew.jovinelli@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    A--Jackson Heart Study - Coordinating Center Renewal
    Currently viewing
    Presolicitation
    A--Jackson Heart Study - Coordinating Center Renewal
    Sources Sought
    Similar Opportunities
    NIH IRP Project, Program, and Portfolio (P3) Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is announcing a special notice regarding the modification of Contract No. 75N98022D00019, awarded to Black Canyon Consulting, LLC (BCC), for Project, Program, and Portfolio (P3) Support Services. The objective of this modification is to increase the contract ceiling by $60 million, raising the total from approximately $95.76 million to $155.76 million, to ensure the continuation of critical, specialized services that support NIH's Intramural Research Program (IRP) amidst ongoing public health challenges. This contract is vital for maintaining operational continuity and enhancing NIH's capacity to address biomedical and clinical research activities, particularly in response to emerging health threats. Interested parties may submit their capabilities for consideration by September 24, 2024, with inquiries directed to Tednette White at tednette.white@nih.gov.
    Industry Collaboration for the Kidney Precision Medicine Project (KPMP)
    Active
    Health And Human Services, Department Of
    Special Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking Industry collaborators for the Kidney Precision Medicine Project (KPMP). This project aims to conduct multi-center clinical and molecular studies in individuals with Diabetic Kidney Disease, Hypertension-related Chronic Kidney Disease, or Acute Kidney Injury. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) of the Department of Health and Human Services (DHHS) is leading this initiative. Industry collaboration is sought to support the research and development efforts in these areas of kidney diseases.
    75N99024R00090 C109584 - Building 105, Providing Standby Power for Chilled Water Generation to Improve Reliability of the Research Triangle Park (RTP) Central Utility Plant (CUP)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health, is soliciting proposals for a design-build project aimed at enhancing the reliability of the Central Utility Plant at Research Triangle Park, North Carolina. The primary objective is to provide standby power for chilled water generation, ensuring continuous cooling for critical research facilities, particularly in the event of electrical utility failures. This project is vital for maintaining operational integrity in laboratories and vivarium environments, where temperature and humidity control are essential for sensitive scientific equipment and research activities. Interested contractors must submit their proposals by September 23, 2024, with an estimated project budget ranging from $25 million to $100 million. For further inquiries, contact Thuy Le at thuy.le@nih.gov or Thao Nguyen at thao.nguyen@nih.gov.
    MANUSCRIPT PREPARATION MANAGEMENT SERVICES
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to provide manuscript preparation management services on a sole source basis with BioCentric, LLC. The contractor will be responsible for a range of tasks including coordinating with authors, assisting in writing and editing manuscripts, developing biomedical illustrations, and managing journal submissions and communications. This contract is a follow-on to an existing agreement and will cover a base year with two option years, emphasizing the importance of high-quality medical writing and publication support in advancing NIH's research objectives. Interested vendors capable of meeting these requirements must submit a capability statement to Ms. Van Holley at holleyv@od.nih.gov by September 18, 2024, at 10 AM EST.
    A--BPCA Pediatric Trials Network
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for an Indefinite Quantity Contract to establish and manage the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network. This initiative aims to create a robust infrastructure for conducting pediatric clinical trials, emphasizing compliance with federal regulations and ethical standards in research practices. The contract, which has a performance period from May 19, 2025, to May 18, 2033, offers a minimum compensation of $2,500 and a maximum potential value of $149 million, contingent on successful performance. Proposals are due by November 4, 2024, and interested parties can contact Elizabeth J. Osinski at eo43m@nih.gov or 240-550-5028 for further information.
    59--NADH/FAD+ Fluorescence lifetime imaging and mScarlet Oxygen Probe
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of NADH/FAD+ Fluorescence lifetime imaging and mScarlet Oxygen Probe. This presolicitation aims to acquire specialized electronic components that are critical for advanced imaging techniques in biomedical research. The goods and services sought are essential for enhancing the understanding of cellular processes and oxygen dynamics in various health-related studies. Interested vendors can reach out to Moses Amawudah at moses.amawudah@nih.gov for further details regarding the procurement process.
    A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) seek proposals from small businesses for innovative research projects under the Small Business Innovation Research (SBIR) program. The upcoming solicitation, PHS-2025-1, will open on August 2, 2024, with a closing date of October 18, 2024, and aims to foster healthcare technological innovation and commercialization. Research topics span cancer research, aging, and various health concerns. Offerors must demonstrate the technical and commercial viability of their proposals. This solicitation invites applications for Phase I, Fast Track, and Direct to Phase II projects, with evaluations based on scientific merit, commercial potential, and performance quality. Successful small businesses could receive funding for their research initiatives, contributing to NIH and CDC mission objectives.
    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Collaborators for NAFLD, NASH & Cryptogenic Cirrhosis Clinical Studies
    Active
    Health And Human Services, Department Of
    Special Notice: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) from the Department of Health and Human Services is seeking industry collaborators for NAFLD, NASH, and Cryptogenic Cirrhosis clinical studies. The NIDDK is looking for partners to collaborate on clinical studies related to these liver diseases. For more information, please refer to the attached Special Notice.
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking qualified small business sources for the NIAID Virology Quality Assurance (VQA) program. The primary objective is to establish a comprehensive quality assessment program for virologic assays related to HIV and other viral pathogens, ensuring the validity and reliability of laboratory data across approximately 110 laboratories globally. This initiative is crucial for maintaining the scientific integrity of ongoing and future studies concerning HIV diagnosis, treatment, and emerging viral pathogens. Interested parties must submit their capability statements by September 26, 2024, to Shawnice Williams at shawnice.williams@nih.gov, with a focus on demonstrating relevant experience and qualifications.
    Using humanized mouse models of NNMT and SULT1A1 for follow-up efficacy studies
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and its National Center for Advancing Translational Sciences (NCATS), intends to award a sole-source contract to GemPharmatech, LLC for follow-up efficacy studies utilizing humanized mouse models of NNMT and SULT1A1. The primary objective of this procurement is to conduct a series of studies, including a Maximum Tolerated Dose (MTD) study, a pharmacokinetic (PK) study, and an efficacy study, to evaluate small molecule inhibitors developed by NCATS, necessitating the creation of mouse models that express human versions of the enzymes involved. This research is critical for advancing the development of therapeutics targeting various human diseases, and the project is expected to span 12 months. Interested parties may submit their capabilities by September 17, 2024, to Michelle Cecilia at michelle.cecilia@nih.gov, with the contract value and specific funding details not disclosed in the announcement.